-
No.1 Scheffler fires sizzling 61 to seize PGA St. Jude lead
-
Arteta tells Arsenal fans not to fret over his future
-
Venezuela frees more political prisoners amid post-Maduro talks
-
Mexico's Indigenous chief justice hits back at discrimination
-
Werro upstages Hodgkinson to win thrilling Euro 800m gold
-
Werro wins 800m race for the ages, Warholm and Tamberi hit four
-
Werro upstages Hodgkinson to win Euro 800m gold
-
Jimenez rescues dramatic Wolves draw in Championship opener
-
Hurricane poised to hit Hawaii as El Nino stirs Pacific
-
Taliban govt to mark five years ruling Afghanistan
-
Ex-Cambridge professor at centre of plagiarism scandal found dead
-
Stocks slip in cautious trading after weak US retail sales data
-
Wildfire threatens Canada wine region
-
Gramercy Networks Announces New Global Ultra-Low Latency Financial Network Connecting Major Trading Hubs
-
'Normal guy' turned killer over US insurance industry grievances
-
NFL bans Falcons defender Pearce eight games for domestic violence
-
Norway's hurdles king Warholm wins fourth European title
-
US says 19 million recalled eggs pose deadly risk
-
Liverpool deal with Bezos consortium raises stakes in US battle for Premier League power
-
Former Cincinnati contenders suffer contrasting first-round fates
-
Colombia hopes for miracles as search for quake victims goes on
-
Argentina's Romero confirms Tottenham exit as Atletico move looms
-
Popovici, Quadarella mine more gold at Europeans as Marchand flexes in butterfly
-
Homeless, jobless: Colombia quake survivors 'left with nothing'
-
'I shot Mr Thompson': Stunning confession in US health exec's slaying
-
Cubans find rest on rooftops as blackouts drive them from home
-
San Francisco to host 2028 MLB All-Star Game
-
World champ McIntosh crashes out of Pan Pacs 400m free
-
Trump dismisses concerns over conditions on US aircraft carrier
-
T'Wolves set Garnett celebration for Celtics clash
-
Zambia resumes vote count after pause over violence
-
Popovici nails freestyle double with third men's European 200m gold
-
Wind spurs forest fire in western Germany, with scores evacuated
-
Premier League club Liverpool sell minority stake to Jeff Bezos consortium
-
Pakistan captain Babar in injury scare ahead of England opener
-
Italian police recover stolen Renoir, Cezanne and Matisse works
-
Mangione admits shooting health care CEO
-
Stocks slip in cautious trading, oil turns higher
-
UN warns sanctions chill is stopping Cuba aid
-
Colombia quake survivor faces life without triplet sisters
-
Alleged US healthcare CEO killer says will plead guilty to stalking
-
Bones of medieval kings saved from Spanish wildfire
-
France's Macron in hot water over jet ski picture
-
US retail sales weakest in over a year, consumer sentiment plunges
-
Nursing federation demands proper pay, protection on Ebola front line
-
In wildfire town, PM says UK must 'face up to climate change'
-
France upholds assisted dying law, strikes down social media ban for children
-
In town hit by wildfire, PM says UK must 'face up to climate change'
-
Body found after wildfire hits Croatian coastal town
-
UK parliament probe into Farage resumes after polls win
US panel recommends nonprescription use of contraception pill
A US panel of health experts voted Wednesday in favor of making birth control pills available without a prescription, a move backed by reproductive rights advocates especially in the wake of a Supreme Court ruling overturning the national right to abortion.
The independent panel voted unanimously that the benefits of allowing the medicine, Opill, to be sold over the counter, outweighed the risks and would reduce hurdles associated with visiting a doctor that impact lower income groups disproportionately.
"I believe that the efficacy and safety of this birth control form was established over half a century ago," said panelist Jolie Haun of the James A. Haley Veterans' Hospital.
"We now have been presented with ample data demonstrating the effective safe use and benefits for people who want to have access to reproductive autonomy."
The committee's votes are usually accepted by the Food and Drug Administration, which means the pill, which is made by HRA Pharma, might be available without prescription in the coming weeks.
While likely, approval is not assured. FDA scientists highlighted safety concerns, such as the potential impact on people with a history or current diagnosis of breast cancer, or whether they would understand the pill needs to be taken the same time every day to prevent pregnancy.
"There is also concern that some consumers may not consistently use the product correctly on a chronic basis and be at risk for pregnancy, but not recognize that they are pregnant because of the irregular bleeding that would be ascribed to the known side effect," the FDA wrote in a document.
The push for a non-prescription pill has taken on new urgency in light of a Supreme Court decision overturning the constitutional right to abortion, leading to numerous bans and severe restrictions in conservative states.
It has received support from health groups such as the American Medical Association and American College of Obstetricians and Gynecologists.
If the pill is approved, the US would join more than 100 other countries where the pill is available without a prescription, including the UK which requires a consultation with a pharmacist.
Opill is known as a "mini pill" because it contains progestin only.
Another company, Cadence, is in talks with the FDA about making its combination pill, which contains both estrogen and progestin, available over the counter.
J.AbuShaban--SF-PST